Safety, cost and effectiveness issues with disease modifying anti-rheumatic drugs in rheumatoid arthritis

Ann Rheum Dis. 1999 Nov;58 Suppl 1(Suppl 1):I86-9. doi: 10.1136/ard.58.2008.i86.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Antirheumatic Agents / economics
  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Rheumatoid / drug therapy*
  • Arthritis, Rheumatoid / economics
  • Health Care Costs
  • Humans
  • Treatment Outcome

Substances

  • Antirheumatic Agents